Related Experiment Videos
Distribution of GAP-43-immunoreactive structures in the human fetal amygdala
1Department of Anatomy, University of Rostock, Germany. norbert.ulfig@med.uni.rostock.de
Insights
Growth-associated protein GAP-43 (Growth-associated protein GAP-43) shows distinct patterns in the developing amygdala, indicating sequential monoaminergic innervation and synaptogenesis. Its presence changes from fibrous to punctate, then disappears by the 9th gestational month.
Area of Science:
- Neuroscience
- Developmental Biology
- Immunohistochemistry
Background:
- Growth-associated protein GAP-43 (Growth-associated protein GAP-43) is crucial for neuronal contact formation.
- GAP-43 exhibits fibrous immunoreactivity during axonal elongation and punctate immunoreactivity during synaptogenesis.
Purpose of the Study:
- To investigate the temporal and spatial distribution of GAP-43 in the developing human amygdala.
- To correlate GAP-43 expression patterns with amygdala development and monoaminergic innervation.
Main Methods:
- Immunohistochemical analysis of GAP-43 expression in human fetal amygdala at different gestational ages (5th, 7th, and 9th months).
- Observation of fibrous versus punctate GAP-43 immunoreactivity patterns within specific amygdaloid nuclei.
Main Results:
- Differential GAP-43 immunoreactivity observed: fibrous in basolateral nuclei and punctate in corticomedial nuclei at the 5th month.
- Shift to exclusively punctate GAP-43 immunoreactivity across all amygdaloid nuclei by the 7th month.
- Absence of GAP-43 immunoreactivity in the amygdala by the 9th month.
Conclusions:
- The differential and dynamic distribution of GAP-43 suggests sequential monoaminergic innervation of amygdaloid nuclei.
- GAP-43 serves as a valuable marker for studying axonal growth and synaptogenesis in the developing human brain.
- Late GAP-43 expression in nuclei like the lateral or basal nucleus correlates with higher cortical processing hierarchies.
Abstract:
The growth-associated protein GAP-43 is a developmentally regulated protein which is involved in the formation of neuronal contacts. In immunohistochemical studies, GAP-43 is detected within axons during their elongation; thus a fibrous immunoreactivity is visible. After axonal growth is completed there is a shift from a fibrous to a punctate immunoreactivity. The latter has been shown to correlate with synaptogenesis. In the amygdala of the 5th gestational month, a fibrous GAP-43-immunoreactivity is seen in the basolateral nuclei, whereas the corticomedial nuclei exclusively show a punctate immunoreactivity. In the 7th month, all amygdaloid nuclei display immunoreactive puncta, but no fibers. In the 9th month GAP-43-immunoreactivity is no longer visible within the amygdala. The results demonstrate the differential distribution of GAP-43-immunoreactive structures in the amygdaloid nuclei. The nuclear specific immunostaining and its changes may indicate the sequential appearance of the monoaminergic innervation of the amygdala, as GAP-43 is known to occur in monoaminergic systems. Nuclei involved in high levels of the cortical processing hierarchy such as the lateral or basal nucleus display a late occurrence of GAP-43-immunoreactivity. In general, anti-GAP-43 has been shown to be an appropriate tool to investigate axonal growth and synaptogenesis in the developing human brain.